| Literature DB >> 36227918 |
Tomasz Zaprutko1, Dorota Kopciuch1, Anna Paczkowska1, Józefina Sprawka2, Julia Cynar2, Monika Pogodzińska2, Katarzyna Niewczas2, Aleksandra Stolecka2, Maria Sygit2, Michał Michalak3, Piotr Ratajczak1, Krzysztof Kus1.
Abstract
Over the last decade, we've observed an enormous social media development, which have recently become commercial services. Hence, we aimed to verify if Facebook might be considered as a source of access to medicines. We also intended to identify prescription (Rx) and over the counter (OTC) medicines if available on that platform. The study was conducted from January 2019 to July 2020. We investigated offers of pharmaceuticals posted on Facebook (individual posts and communities) between 2016 and 2019. Medicines were divided into Rx and OTC brands and in accordance with their possible therapeutic use. We verified whether the medicines were for sale, to exchange, or available for free. Posts and groups were investigated for example, by entering the phrase "for free," followed by a city in Poland. Out of 409 offers, 380 (92.91%) concerned Rx brands and 29 (7.09%) OTC brands. 315 (77.02%) medications were available "for free". In 47 (11.49%) cases, an "exchange" was expected, and 47 (11.49%) announcements were marked as "for sale". Cardiovascular medicines (n = 125; 30.56%) were the most popular. There were also antidiabetics (n = 38; 9.29%) and antipsychotics (n = 28; 6.84%). We also found clear candidates for misuse. These were opioids (n = 7; 1.71%), benzodiazepines (n = 2; 0.48%), clomifene (n = 1; 0.24%), and letrozole (n = 1; 0.24%). Facebook provides the possibility of uncontrolled access to medicines. The majority of offers concerned Rx brands, including opioids and benzodiazepines. Medicines offered on Facebook were mainly accessible for free. The scope and the number of medications offered on Facebook should make this issue a hazardous phenomenon.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36227918 PMCID: PMC9560064 DOI: 10.1371/journal.pone.0275272
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1The example of the illegal online trade of medicines.
Offer including morphine (Sevredol®) and tramadol (Polram Combo®). Source: Facebook. The URL address was not collected and is not reported to avoid the possible traceability of the Facebook user and to not to contravene the data protection or the GDPR. The presented figure is similar but not identical (partial screenshot with concealed parts of the picture) to the original image and is therefore only for illustrative purposes.
Fig 3The example of the illegal online trade of medicines.
Offer for palbociclib (Ibrance®). Source: Facebook. The URL address was not collected and is not reported to avoid the possible traceability of the Facebook user and to not to contravene the data protection or the GDPR. The presented figure is similar but not identical (partial screenshot with concealed parts of the picture) to the original image and is therefore only for illustrative purposes.
The examples of medicines found on Facebook.
| Medicines from Facebook | Medicines category | Number of advertised medicines | Number of medicines offered „for sale” | Example of the found medicine (brand name/substance/ATC Code) | Price of presented example in Euro (€) |
|---|---|---|---|---|---|
| 409 offers found in the study | Cardiovascular including novel oral anticoagulants | n = 125 (30.56%) | 3 | Dopegyt® / 250 mg Methyldopa / C02AB01 | € 6.74 |
| Hormones | n = 26 (6.35%) | 4 | Duphaston® / 10 mg Dydrogesterone / G03DB01 | € 3.37 | |
| Anticoagulants | n = 17 (4.15%) | 2 | Clexane® / 40 mg enoxaparin sodium / B01AB05 | € 3.37 | |
| Antihistamines | n = 13 (3.17%) | 1 | CetAlergin® / 10 mg cetirizine dihydrochloride / R06AE07 | € 1.12 | |
| Others | n = 87 (21.27%) | 4 | Mysimba® / 8mg naltrexone hydrochloride+ 90 mg bupropion hydrochloride / A08AA62 | € 78.60 |
#We present only these groups of medicines where the exact retail price was indicated.
$The number concerns all analyzed offers for medicines.
The structure of offers related to opioids, benzodiazepines, and anti-cancer medicines.
| Opioids n = 7 | Benzodiazepines n = 2 | Anti-cancer medicines n = 7 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Morphine | Tramadol | Oxycodone | Estazolam | Zolpidem | Megestrol | Palbociclib | Ondansetron | Filgrastim | Letrozole | |
| n = 2 | n = 4 | n = 1 | n = 1 | n = 1 | n = 2 | n = 2 | n = 1 | n = 1 | n = 1 | |
|
| n = 2 | n = 4 | n = 1 | n = 1 | n = 1 | n = 2 | n = 2 | n = 1 | n = 1 | N/A |
|
| N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | n = 1 |
N/A–not applicable.
# There were no offers for the exchange within these groups of medicines.
^ Negotiable price.
Fig 4Goods expected in exchange for medicines.